Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

AVIR holding history

Atea Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVIR overviewAll 13F holders of AVIRFull Q2 2026 holdings

Shares (Q2 2026)
345,186
Value
$1.61M
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of AVIR by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026345,186$1.61M<0.1%−34,128−9.0%ReducedHolders
Q1 2026379,314$2.04M<0.1%−85,473−18.4%ReducedHolders
Q4 2025464,787$1.66M<0.1%+100,019+27.4%AddedHolders
Q3 2025364,768$1.06M<0.1%+168,916+86.2%AddedHolders
Q2 2025195,852$705.1K<0.1%−148,693−43.2%ReducedHolders
Q1 2025344,545$1.03M<0.1%+88,462+34.5%AddedHolders
Q4 2024256,083$857.9K<0.1%+62,505+32.3%AddedHolders
Q3 2024193,578$648.5K<0.1%+45,665+30.9%AddedHolders
Q2 2024147,913$489.6K<0.1%−59,846−28.8%ReducedHolders
Q1 2024207,759$839.3K<0.1%+22,582+12.2%AddedHolders
Q4 2023185,177$564.8K<0.1%+115,228+164.7%AddedHolders
Q3 202369,949$209.8K<0.1%−13,473−16.2%ReducedHolders
Q2 202383,422$312.0K<0.1%+33,724+67.9%AddedHolders
Q1 202349,698$166.5K<0.1%+9,476+23.6%AddedHolders
Q4 202240,222$193.5K<0.1%+11,065+37.9%AddedHolders
Q3 202229,157$166.0K<0.1%+29,157NewHolders
Q1 20220$00.0%−19,404−100.0%Sold outHolders
Q4 202119,404$173.0K<0.1%+19,404NewHolders
Q2 20210$00.0%−28,187−100.0%Sold outHolders
Q1 202128,187$1.74M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.